Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000152158 | SCV000200861 | benign | not specified | 2013-02-21 | criteria provided, single submitter | clinical testing | 2546-12C>T in intron 22 of TSC2: This variant is not expected to have clinical s ignificance because it has been identified in 47.9% (2106/4396) of African Ameri can chromosomes from a broad population by the NHLBI Exome Sequencing Project (h ttp://evs.gs.washington.edu/EVS; dbSNP rs13331451). |
Eurofins Ntd Llc |
RCV000152158 | SCV000228021 | benign | not specified | 2014-10-16 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000152158 | SCV000305178 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000042472 | SCV000395613 | benign | Tuberous sclerosis syndrome | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Gene |
RCV001650881 | SCV001862506 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001797600 | SCV002039209 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001650881 | SCV002050164 | benign | not provided | 2024-11-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001797600 | SCV002402167 | benign | Tuberous sclerosis 2 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV001797600 | SCV004016103 | benign | Tuberous sclerosis 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001797600 | SCV004360882 | benign | Tuberous sclerosis 2 | 2019-03-28 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000042472 | SCV004822675 | benign | Tuberous sclerosis syndrome | 2024-10-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001650881 | SCV005297719 | benign | not provided | criteria provided, single submitter | not provided | ||
Tuberous sclerosis database |
RCV000042472 | SCV000066263 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation | ||
Clinical Genetics, |
RCV000152158 | SCV001922200 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000152158 | SCV001971791 | benign | not specified | no assertion criteria provided | clinical testing |